HomeCompareSIXGF vs ABBV

SIXGF vs ABBV: Dividend Comparison 2026

SIXGF yields 4.70% · ABBV yields 3.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SIXGF wins by $4338.27M in total portfolio value
10 years
SIXGF
SIXGF
● Live price
4.70%
Share price
$79.18
Annual div
$3.72
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4338.37M
Annual income
$4,167,944,189.63
Full SIXGF calculator →
ABBV
AbbVie Inc.
● Live price
3.06%
Share price
$217.44
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.3K
Annual income
$24,771.77
Full ABBV calculator →

Portfolio growth — SIXGF vs ABBV

📍 SIXGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSIXGFABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SIXGF + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SIXGF pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SIXGF
Annual income on $10K today (after 15% tax)
$399.34/yr
After 10yr DRIP, annual income (after tax)
$3,542,752,561.19/yr
ABBV
Annual income on $10K today (after 15% tax)
$259.96/yr
After 10yr DRIP, annual income (after tax)
$21,056.00/yr
At 15% tax rate, SIXGF beats the other by $3,542,731,505.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SIXGF + ABBV for your $10,000?

SIXGF: 50%ABBV: 50%
100% ABBV50/50100% SIXGF
Portfolio after 10yr
$2169.24M
Annual income
$2,083,984,480.69/yr
Blended yield
96.07%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

SIXGF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
1.7
Piotroski
4/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+17.8% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SIXGF buys
0
ABBV buys
0
No recent congressional trades found for SIXGF or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSIXGFABBV
Forward yield4.70%3.06%
Annual dividend / share$3.72$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%40.6%
Portfolio after 10y$4338.37M$102.3K
Annual income after 10y$4,167,944,189.63$24,771.77
Total dividends collected$4326.35M$61.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: SIXGF vs ABBV ($10,000, DRIP)

YearSIXGF PortfolioSIXGF Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$11,640$939.63$11,550$430.00+$90.00SIXGF
2$14,499$2,044.29$13,472$627.96+$1.0KSIXGF
3$20,273$4,759.69$15,906$926.08+$4.4KSIXGF
4$34,132$12,440.00$19,071$1,382.55+$15.1KSIXGF
5$75,670$39,148.00$23,302$2,095.81+$52.4KSIXGF
6$243,189$162,222.29$29,150$3,237.93+$214.0KSIXGF
7$1,234,704$974,492.37$37,536$5,121.41+$1.20MSIXGF
8$10,569,052$9,247,918.25$50,079$8,338.38+$10.52MSIXGF
9$159,275,323$147,966,437.53$69,753$14,065.80+$159.21MSIXGF
10$4,338,368,785$4,167,944,189.63$102,337$24,771.77+$4338.27MSIXGF

SIXGF vs ABBV: Complete Analysis 2026

SIXGFStock

Sixt SE, through its subsidiaries, provides mobility services for private and business customers in Germany and internationally. The company offers mobility service across the fields of vehicle and commercial vehicle rental, car sharing, ride hailing, and car subscriptions. It has a network of 2,115 stations. The company was founded in 1912 and is headquartered in Pullach, Germany. Sixt SE is a subsidiary of Erich Sixt Vermögensverwaltung GmbH.

Full SIXGF Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this SIXGF vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SIXGF vs SCHDSIXGF vs JEPISIXGF vs OSIXGF vs KOSIXGF vs MAINSIXGF vs JNJSIXGF vs MRKSIXGF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.